PSA and clinical examination
Assessment of total and free PSA, PSA density and kinetics. Digital rectal exam when indicated. Interpretation in the clinical context.
Dr. Bruno Benigno is a urologic oncologist working in robotic surgery, multiparametric MRI, fusion biopsy and PET-PSMA. Here, you do not choose alone between surgery, radiotherapy or active surveillance — we decide together, based on evidence.
CRM-SP 126265 • RQE Urology
Watch the video to understand our technical and caring approach to urologic diagnosis and treatment.
A poorly made diagnosis costs years of quality of life. Our workup follows international protocols and individualizes every step.
Assessment of total and free PSA, PSA density and kinetics. Digital rectal exam when indicated. Interpretation in the clinical context.
The current standard for locating suspicious lesions before biopsy. A PI-RADS report enables a safer decision.
Biopsy guided by fusing MRI images with ultrasound. Greater accuracy and fewer unnecessary procedures.
Direct oncologic control with magnified three-dimensional vision, articulated instruments and neurovascular preservation.
An approach for locally advanced cases or patients who are not surgical candidates, aiming for efficient outpatient disease control.
A strategy for indolent, low-risk tumors that avoids immediate adverse effects through rigorous monitoring.
A clear process, with no surprises. From first contact to post-treatment follow-up.
Screening by our team, in-person or telemedicine scheduling, and guidance on documents and prior tests.
Detailed medical history, review of tests, ordering of additional exams. Treatment plan discussed with you and your family.
Robotic surgery, referral to a leading radiotherapy center or an active surveillance protocol — with continuous support.
Long-term follow-up, pelvic floor physiotherapy, sexual rehabilitation and ongoing PSA monitoring.
Spaces designed for the warmest welcome and state-of-the-art surgical technology.




















"I went to Dr. Bruno for a second opinion after being told I needed immediate surgery. He reviewed my tests, calmly explained each option and offered me active surveillance. Today I am doing well, without surgery."
"Robotic surgery was much less traumatic than I expected. I was discharged within 24 hours, regained continence in a few weeks and my PSA remains undetectable."
"Technically excellent and humane care. He explained the PET-PSMA and the radiotherapy plan in a way that my wife and I understood every step."
Established partnerships with leading medical centers in São Paulo.
If you have been diagnosed with prostate cancer, have an elevated PSA or have been advised to undergo treatment and would like a specialist assessment, book a consultation.
In-person consultations in São Paulo · Telemedicine throughout Brazil
The information on this page is based on the guidelines and studies below, published in peer-reviewed medical journals.
European (EAU) guideline updated in 2024: screening, MRI-based diagnosis and treatment with curative intent.
American (AUA/ASTRO) guideline on risk stratification and treatment selection for localized prostate cancer.
European randomized study with 16 years of follow-up: PSA screening reduced prostate cancer mortality.
ProtecT randomized trial, with 15 years of follow-up, comparing active monitoring, surgery and radiotherapy in localized prostate cancer.
PRECISION randomized trial: MRI before biopsy increased the detection of clinically significant cancer and reduced the diagnosis of insignificant tumors.
Medical content reviewed by Dr. Bruno Benigno, urologist and uro-oncologist (CRM-SP 126.265 · RQE 60022), based on AUA, EAU and NCCN guidelines. Last reviewed: